1. Home
  2. BSBK vs STIM Comparison

BSBK vs STIM Comparison

Compare BSBK & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bogota Financial Corp.

BSBK

Bogota Financial Corp.

HOLD

Current Price

$9.06

Market Cap

108.0M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.39

Market Cap

88.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSBK
STIM
Founded
1893
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.0M
88.4M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
BSBK
STIM
Price
$9.06
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
8.8K
1.3M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
200.00
57.25
EPS
0.06
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
$151.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$0.80
52 Week High
$9.49
$4.84

Technical Indicators

Market Signals
Indicator
BSBK
STIM
Relative Strength Index (RSI) 57.00 55.17
Support Level $8.83 $1.21
Resistance Level $9.29 $1.42
Average True Range (ATR) 0.12 0.11
MACD -0.02 0.02
Stochastic Oscillator 62.50 61.54

Price Performance

Historical Comparison
BSBK
STIM

About BSBK Bogota Financial Corp.

Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey. The Company operates one reportable segment of business, retail banking. Through its community banking segment, the Company provides a broad range of retail and commercial banking services.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: